|
|
||||||||
AJP - Renal Physiology, Vol 255, Issue 6 1085-F1090, Copyright © 1988 by American Physiological Society
ARTICLES |
A. Mimran, J. Nussberger, J. Ribstein, B. Waeber and H. R. Brunner
Department of Medicine, Centre Hospitalier Universitaire, Montpellier, France.
To further investigate the mechanism(s) of the exaggerated natriuretic response of hypertensives to volume expansion (VE; 1,800 ml iv isotonic saline over 3 h), the plasma levels of immunoreactive atrial natriuretic peptide (ANP) were measured in 11 normal subjects (NT) and 12 patients with mild essential hypertension (HT). NT and HT groups were similar with respect to age and basal levels of renin, aldosterone and ANP (34.5 +/- 5.5 in NT and 32.5 +/- 6.3 pg/ml in HT, mean +/- SE). In response to VE, ANP increased to the same extent in both groups (a change of 19.3 +/- 5.2 in NT and of 22.2 +/- 7.1 pg/ml in HT) despite the finding of an exaggerated natriuretic response to VE in essential hypertension (36 +/- 3.5 in NT and 54.9 +/- 6.3 nmol/3 h in HT, P less than 0.02). In addition, the fall in hematocrit and serum protein associated with saline infusion was less marked in HT than NT. The change in ANP induced by VE was inversely correlated with the percent fall in hematocrit and the increment in the fractional excretion of sodium in both groups. These observations suggest that ANPs may participate in the control of the renal response to isotonic VE; however they do not support an unequivocal influence of ANP in the exaggerated natriuretic response to VE of patients with essential hypertension.
This article has been cited by other articles:
![]() |
S. K. Dubois, I. Kishimoto, T. O. Lillis, and D. L. Garbers A genetic model defines the importance of the atrial natriuretic peptide receptor (guanylyl cyclase-A) in the regulation of kidney function PNAS, April 11, 2000; 97(8): 4369 - 4373. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Campese, M. Tawadrous, R. Bigazzi, S. Bianchi, A. S. Mann, S. Oparil, and L. Raij Salt Intake and Plasma Atrial Natriuretic Peptide and Nitric Oxide in Hypertension Hypertension, September 1, 1996; 28(3): 335 - 340. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |